Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
about
Tumor necrosis factor-alpha inhibitor treatment for sarcoidosisA Clinical Picture of the Visual Outcome in Adamantiades-Behçet's DiseaseAnti-TNF therapy for juvenile idiopathic arthritis-related uveitisCytokines and Biologics in non-infectious autoimmune uveitis: bench to bedsideBiologics in dermatology: an integrated reviewThe Future Is Now: Biologics for Non-Infectious Pediatric Anterior UveitisIntravenous laser blood irradiation increases efficacy of etanercept in selected subtypes of juvenile idiopathic arthritis: an innovative clinical research approach.Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case seriesAn update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review.Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) RegistryHigh-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis.Response of pediatric uveitis to tumor necrosis factor-α inhibitors.Emerging role of antioxidants in the protection of uveitis complications.Current evidence of anti-tumor necrosis factor α treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs.Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.A case of neurosarcoidosis secondary to treatment of etanercept and review of the literature.Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up.Current perspectives on ophthalmic manifestations of childhood rheumatic diseasesPrevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitisAdalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers.Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis.Clinical review: Anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience.Etanercept: efficacy and safety for approved indications.Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.Biological agents for the treatment of uveitis.Biologic agents in inflammatory eye disease.Adding to complexity: comorbidity in paediatric rheumatic disease.A systematic review of biologics for the treatment of noninfectious uveitis.Biologic agents in experimental autoimmune uveitis.Overview and recent developments in the medical management of paediatric uveitis.Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.Therapy of ocular Behçet disease.Treatment of uveitis associated with juvenile idiopathic arthritis.Pathophysiology of JIA-associated uveitis.The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms.Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.Current Treatment Modalities of JIA-associated Uveitis and its Complications: Literature Review.
P2860
Q24652971-D631F10B-4B19-47D2-8A45-A11BCC64D9D1Q26777598-1CEE2B65-1AEB-41F9-8E62-DB4205D8361AQ26849811-21588E48-08AC-4601-B3CF-B09ECAF9B33FQ26852585-77AC7A29-2D90-405E-B5E6-6EC3B029F1BFQ27004638-29872722-8D06-493F-9A8A-FA5F8DFF751CQ27025862-CE75982F-E2AD-4840-BCF6-3D14DF15BF89Q31130038-CE3F4FFA-233A-43DC-8609-0034EBBE5FECQ33712570-CB058255-2AD9-46DF-B0A5-4CCE428AC84FQ33910781-F2A6A908-1E74-405B-81A9-D6599FA1CC9BQ33981536-C9C982FA-682D-44AE-89B4-1F0A6FE00F2CQ34070773-FF672683-A545-49C1-BA19-FE393E1715BAQ34789195-E7A4CBD9-957D-4979-BE57-921E1EA3D0E4Q34887046-FDED4716-1196-459F-8368-BDAAFC2AE492Q35150941-627EFC8E-F43B-4E40-A30E-624231BA32A9Q35760145-963C4192-C993-464A-B68D-EEF563FAA68EQ35823618-6DC44186-F50A-4183-9C38-D58A47D390C3Q35825121-2AAB3B53-9230-4936-B1FE-C04A1DC38000Q37007652-52CBBB10-63D2-4187-8562-2626D9D27F8BQ37115017-2D971FFA-A4D3-4C08-B5C9-7EBB7651BEB6Q37146227-E6EB5862-50F1-4C9D-9742-5AE3430FF559Q37195338-475D3454-4FA0-4658-9EBA-23B2922BBA8CQ37290665-05279F8D-AAA4-4829-833B-19AF577CB664Q37479820-FD5D873B-51F8-4759-BDC3-A24572F7EE17Q37482393-89AEC3BD-DB43-48E4-A8A1-5D2513DD3400Q37650221-1A7D555F-DB93-4F7E-ADDA-A5591F8FFE9FQ37954714-342ADBB5-12B4-4FDA-864A-963872E3FC46Q37956187-C9EF4251-6A2F-439B-B4A9-B825F44CCF32Q37984565-3DDE205C-DDB7-48C3-AA29-1C31560A6812Q37997772-6D17DC34-6F32-4DAD-8EFE-5C1BEAFC2A55Q38048234-92D0C802-D63B-4850-AF58-EAFE51BEC440Q38068969-7293A1FB-08DB-4E44-B8B2-47DC3425F3DEQ38089645-A0877820-9495-41E7-B00F-88D032F4DFC5Q38119243-56B34452-884D-47E6-BF02-A527FF581A33Q38144094-7EC38748-0F25-4846-8D38-2C0EF7D32357Q38174652-37B31C21-DE00-4612-B255-603D20045B04Q38221012-05CA41D4-8EC4-4991-95F6-302203B0BC31Q38225611-22F0EE0C-63D9-4120-B14A-8421638A3E08Q38245648-391AAF61-6C45-4B1D-B4F3-343DB1AC17ADQ38664517-5FBE16A8-3DFB-4986-8D7D-C9AB3DD10131Q38696180-38700849-833A-489C-9C05-05D3029F07BB
P2860
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
@ast
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
@en
type
label
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
@ast
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
@en
prefLabel
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
@ast
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
@en
P2093
P2860
P356
P1433
P1476
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis
@en
P2093
Feldman BM
Rabinovitch T
Saurenmann RK
Schneider R
Silverman ED
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEL030
P577
2006-02-03T00:00:00Z